NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to ILMN. ILMN was compared to 55 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ILMN get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on ILMN.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -19.39% | ||
ROE | -51.5% | ||
ROIC | 10.73% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 14.78% | ||
PM (TTM) | N/A | ||
GM | 65.44% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.81 | ||
Altman-Z | 2.7 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.78 | ||
Quick Ratio | 1.42 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 29.02 | ||
Fwd PE | 15.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 15.87 | ||
EV/EBITDA | 11.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:ILMN (4/21/2025, 1:59:09 PM)
71.1
-0.1 (-0.14%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 29.02 | ||
Fwd PE | 15.64 | ||
P/S | 2.57 | ||
P/FCF | 15.87 | ||
P/OCF | 13.44 | ||
P/B | 4.74 | ||
P/tB | 11.66 | ||
EV/EBITDA | 11.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -19.39% | ||
ROE | -51.5% | ||
ROCE | 13.58% | ||
ROIC | 10.73% | ||
ROICexc | 14.43% | ||
ROICexgc | 23.98% | ||
OM | 14.78% | ||
PM (TTM) | N/A | ||
GM | 65.44% | ||
FCFM | 16.22% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.81 | ||
Debt/EBITDA | 1.49 | ||
Cap/Depr | 36.16% | ||
Cap/Sales | 2.93% | ||
Interest Coverage | 7.78 | ||
Cash Conversion | 83.7% | ||
Profit Quality | N/A | ||
Current Ratio | 1.78 | ||
Quick Ratio | 1.42 | ||
Altman-Z | 2.7 |